Altimmune Inc (ALT)
4.92
-0.10 (-1.99%)
USD |
NASDAQ |
May 23, 13:27
Altimmune Price to Book Value: 1.150 for May 23, 2022
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 20, 2022 | 1.174 |
| May 19, 2022 | 1.127 |
| May 18, 2022 | 1.132 |
| May 17, 2022 | 1.237 |
| May 16, 2022 | 1.124 |
| May 13, 2022 | 1.206 |
| May 12, 2022 | 1.001 |
| May 11, 2022 | 0.9211 |
| May 10, 2022 | 0.9983 |
| May 09, 2022 | 0.9702 |
| May 06, 2022 | 1.012 |
| May 05, 2022 | 1.024 |
| May 04, 2022 | 1.092 |
| May 03, 2022 | 1.110 |
| May 02, 2022 | 1.104 |
| April 29, 2022 | 1.057 |
| April 28, 2022 | 1.073 |
| April 27, 2022 | 1.057 |
| April 26, 2022 | 1.038 |
| April 25, 2022 | 1.096 |
| April 22, 2022 | 1.061 |
| April 21, 2022 | 1.064 |
| April 20, 2022 | 1.146 |
| April 19, 2022 | 1.206 |
| April 18, 2022 | 1.188 |
| Date | Value |
|---|---|
| April 14, 2022 | 1.223 |
| April 13, 2022 | 1.286 |
| April 12, 2022 | 1.288 |
| April 11, 2022 | 1.342 |
| April 08, 2022 | 1.328 |
| April 07, 2022 | 1.382 |
| April 06, 2022 | 1.393 |
| April 05, 2022 | 1.368 |
| April 04, 2022 | 1.480 |
| April 01, 2022 | 1.454 |
| March 31, 2022 | 1.424 |
| March 30, 2022 | 1.313 |
| March 29, 2022 | 1.374 |
| March 28, 2022 | 1.348 |
| March 25, 2022 | 1.387 |
| March 24, 2022 | 1.472 |
| March 23, 2022 | 1.491 |
| March 22, 2022 | 1.517 |
| March 21, 2022 | 1.485 |
| March 18, 2022 | 1.565 |
| March 17, 2022 | 1.530 |
| March 16, 2022 | 1.426 |
| March 15, 2022 | 1.281 |
| March 14, 2022 | 1.396 |
| March 11, 2022 | 1.511 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1709
Minimum
Sep 18 2018
13.39
Maximum
Jul 20 2020
1.529
Average
0.8068
Median
Price to Book Value Benchmarks
| Sage Therapeutics Inc | 1.164 |
| Spero Therapeutics Inc | 0.7145 |
| Savara Inc | 1.095 |
| Catalyst Pharmaceuticals Inc | 3.262 |
| Geron Corp | 4.975 |
Price to Book Value Related Metrics
| PS Ratio | 57.77 |
| PEG Ratio | -0.1058 |
| Price | 4.92 |
| Earnings Yield | -49.19% |
| Market Cap | 212.64M |